Court rules companies can’t import Gilead medications from overseas in blow to AFP health programs

A U.S. appeals court has ruled in favor of Gilead Sciences against companies known as alternative funding programs that import medicines from overseas.

A U.S. appeals court has ruled in favor of Gilead Sciences against companies known as alternative funding programs that import medicines from overseas.

About the Author

Leave a Reply

Your email address will not be published. Required fields are marked *